Viewing StudyNCT00307125



Ignite Creation Date: 2024-05-05 @ 4:44 PM
Last Modification Date: 2024-10-26 @ 9:23 AM
Study NCT ID: NCT00307125
Status: COMPLETED
Last Update Posted: 2015-03-23
First Post: 2006-03-23

Brief Title: Rituximab in Renal Allograft Recipients Who Develop Early De Novo Anti-HLA Alloantibodies
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
de Novo HLA Antibodies Development
Kidney Transplant
Kidney Transplant Recipient
Graft FunctionSurvival
Keywords:
Name View
anti-CD20 rituximab View
Organ Transplantation View
Graft functionsurvival View
Immunosuppression View